Aim: To assess the response to chondroitin sulfate (structum) in low back pain (LBP) due to spinal osteochondrosis.
Material and methods: 30 patients (mean age 51.4 years) with a definite primary LBP took structum in a dose 1 g/day for 24 weeks. The diagnosis was made according to WHO recommendations (2000). The response was assessed with uniform international questionnaires and visual analogue scale.
Results: The treatment reduced pain syndrome and improved spinal function in 73.3% patients with LBP studied.
Conclusion: It would be valid to include long-acting chondroprotective drugs in the program of LBP in spinal osteochondrosis.